StockNews.com began coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Free Report) in a report issued on Thursday morning. The brokerage issued a sell rating on the basic materials company’s stock.
Arcadia Biosciences Stock Up 2.9 %
Shares of NASDAQ RKDA opened at $6.09 on Thursday. The business has a 50-day simple moving average of $4.57 and a two-hundred day simple moving average of $3.51. Arcadia Biosciences has a 52 week low of $1.85 and a 52 week high of $10.31. The company has a market cap of $8.31 million, a P/E ratio of -1.42 and a beta of 1.19.
Arcadia Biosciences Company Profile
Read More
- Five stocks we like better than Arcadia Biosciences
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- 3 Legacy Tech Companies Reemerging as AI LeadersÂ
- What is Put Option Volume?
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- Pros And Cons Of Monthly Dividend Stocks
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.